Piper Sandler Initiates Coverage On Perspective Therapeutics with Overweight Rating, Announces Price Target of $16
Benzinga Newsdesk 8 months ago
NewsPrice TargetInitiationAnalyst Ratings
Piper Sandler analyst Biren Amin initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Overweight rating and announces Price Target of $16.
Piper Sandler analyst Biren Amin initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Overweight rating and announces Price Target of $16.